Theravance Biopharma, Inc.·4

Jan 23, 6:05 PM ET

Farnum Rhonda 4

4 · Theravance Biopharma, Inc. · Filed Jan 23, 2025

Insider Transaction Report

Form 4
Period: 2025-01-21
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Transactions
  • Sale

    Ordinary Shares

    2025-01-21$9.00/sh4,000$36,000309,565 total

Documents

1 file
  • 4
    form4-01232025_110129.xmlPrimary